BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27283530)

  • 1. The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases.
    Ebert RF; Danthi NS; Charette MF; Hanspal M; Mondoro TH; Noel PJ; Olive M; Punturieri A; Moore TM
    Circ Res; 2016 Jun; 118(12):1867-71. PubMed ID: 27283530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.
    Wood D; Wesselschmidt R; Hematti P; Gee AP; Rooney C; Silberstein L; Armant M; Couture L; Wagner JE; McKenna DH; Hei D; Mondoro TH; Welniak L; Lindblad R
    Clin Transl Sci; 2014 Apr; 7(2):93-9. PubMed ID: 24655892
    [No Abstract]   [Full Text] [Related]  

  • 3. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.
    Shurin SB
    Circulation; 2011 Oct; 124(17):1894-6. PubMed ID: 22025639
    [No Abstract]   [Full Text] [Related]  

  • 4. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program.
    Kibbe MR; Dardik A; Velazquez OC; Conte MS;
    J Vasc Surg; 2015 Apr; 61(4):1050-7. PubMed ID: 25814368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis Research: Extramural Portfolio Supported by the National Heart, Lung, and Blood Institute, 2008-2015.
    Gao Y; Stanley DV; Robinson VC; Reid DM; Galis ZS
    Circ Res; 2017 May; 120(11):1713-1717. PubMed ID: 28546354
    [No Abstract]   [Full Text] [Related]  

  • 6. How one program at the National Heart, Lung, and Blood Institute establishes its scientific priorities.
    Bild DE; Lauer MS
    J Am Coll Cardiol; 2009 Jun; 53(24):2259-61. PubMed ID: 19520248
    [No Abstract]   [Full Text] [Related]  

  • 7. Portfolio analysis on preeclampsia and pregnancy-associated hypertension research funded by the National Heart, Lung, and Blood Institute.
    Maric-Bilkan C
    Physiol Genomics; 2018 Nov; 50(11):982-987. PubMed ID: 30265594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation of genetics research to clinical medicine: the National Heart, Lung, and Blood Institute perspective.
    Puggal MA; Schully SD; Srinivas PR; Papanicolaou GJ; Jaquish CE; Fabsitz RR
    Circ Cardiovasc Genet; 2013 Dec; 6(6):634-9. PubMed ID: 24347619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.
    Galis ZS; Black JB; Skarlatos SI
    Circ Res; 2013 Apr; 112(9):1212-8. PubMed ID: 23620235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical translational science awards: opportunities and challenges.
    Shurin SB
    Clin Transl Sci; 2008 May; 1(1):4. PubMed ID: 20443810
    [No Abstract]   [Full Text] [Related]  

  • 11. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.
    Shurin SB
    Blood; 2011 Nov; 118(20):5380-2. PubMed ID: 21868577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology research support at the National Heart, Lung, and Blood Institute.
    Buxton DB
    Circ Res; 2011 Jul; 109(3):250-4. PubMed ID: 21778434
    [No Abstract]   [Full Text] [Related]  

  • 13. Current NHLBI perspectives on translational heart failure research.
    Lathrop DA; Skarlatos S
    J Mol Cell Cardiol; 2011 Oct; 51(4):441-3. PubMed ID: 20946899
    [No Abstract]   [Full Text] [Related]  

  • 14. NHLBI announces SMARTT program.
    J Investig Med; 2011 Jun; 59(5):744. PubMed ID: 22121528
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial Outcomes for the NHLBI K99/R00 Pathway to Independence Program in Relation to Long-Standing Career Development Programs: Implications for Trainees, Mentors, and Institutions.
    Carlson DE; Wang WC; Scott JD
    Circ Res; 2016 Sep; 119(8):904-8. PubMed ID: 27688307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Productivity Returns on Investment: Thirty Years of Peer Review, Grant Funding, and Publication of Highly Cited Papers at the National Heart, Lung, and Blood Institute.
    Lauer MS; Danthi NS; Kaltman J; Wu C
    Circ Res; 2015 Jul; 117(3):239-43. PubMed ID: 26089369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in NHLBI-Funded Research on Sex Differences in Hypertension.
    Maric-Bilkan C; Galis ZS
    Circ Res; 2016 Aug; 119(5):591-5. PubMed ID: 27539972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. News from NHLBI: Nutrition Research at the National Heart, Lung, and Blood Institute and Future Opportunities.
    Brown AGM; Hyams T; Brown AN; Nicastro H; Pratt CA
    J Nutr; 2021 Mar; 151(3):598-604. PubMed ID: 33561207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National heart, lung, and blood institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025.
    Lauer MS; Kiley JP; Mockrin SC; Mensah GA; Hoots WK; Patel Y; Cook NL; Patterson AP; Gibbons GH
    Circulation; 2015 Mar; 131(12):1106-9. PubMed ID: 25802256
    [No Abstract]   [Full Text] [Related]  

  • 20. Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute.
    Buxton DB; Skarlatos SI
    Circ Res; 2012 Jun; 110(12):1549-55. PubMed ID: 22679137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.